The Hepatitis B & C Public Policy Association was founded in 2009 by a group of leading European scientists, public health experts and patient advocates. We aim to urge and facilitate the formulation of public policies at national and international level for the communication, prevention and management of viral Hepatitis B and C. The Association’s unique approach in furtherance of this aim is to gather together, and work in partnership with, the major stakeholders in the field of these diseases including regulators, patients, clinicians, public health and civil society communities and the private sector.
The first ever EU HCV Policy Summit dedicated to the elimination of hepatitis C in Europe was organised by this association and its partners in February 2016 in Brussels. The Summit was addressed by EU Health Commissioner Andriukaitis, MEPs and national policy-makers.
A second EU HCV summit entitled-«Securing sustainable funding for hepatitis elimination plans took place in 2018 the third EU HCV Summit dedicated to the elimination of the hepatitis C virus (HCV) in Europe entitled «Securing Wider EU Commitment to the Elimination of HCV» took place on line in March 2021.
Three mini national HCVSummits were organised at the European parliament in 2017 dedicated to the elimination of HCV In Romania, Portugal and Greece.
Four more National Mini Summits are planned for 2021/2022.
For more information about the Association’s activities please visit www.hepbcppa.org.
Summit activities: www.hcvbrusselssummit.eu